Review
Copyright ©The Author(s) 2023.
World J Hepatol. Aug 27, 2023; 15(8): 939-953
Published online Aug 27, 2023. doi: 10.4254/wjh.v15.i8.939
Table 4 Inclusion and exclusion criteria for patients with cholangiocarcinoma being considered for Model For End Stage Liver Disease exception points
Inclusion criteria
Exclusion criteria
Evidence of positive tumor cells or cells strongly suspicious for CCA on biopsyEvidence of extra hepatic disease or lymph node enlargement
Malignant appearing stricture on radiograph and 1 of the following criteria (a or b or c)Previous malignancy excluding skin or cervical cancer within 5 yr before diagnosis of cholangiocarcinoma
a. Ca 19-19 > 100 U/mL in the absence of acute bacterial cholangitisHistory of abdominal radiotherapy
b. Polysomy on fluorescence in-situ hybridizationUncontrolled infection before treatment
c. Hilar mass < 3 cm in radial diameter on cross-sectional imagingPrior attempt of surgical tumors reaction and subsequent violation of tumor plane
-Any medical condition precluding transplantation
-Any transperitoneal biopsy including percutaneous and/or endoscopic ultrasonographic-guided fine needle aspiration